AbbVie's strong financial metrics such as high ROE, EBITDA, and gross profit margins indicate robust profitability and operational efficiency, which are positive indicators for investors. However, the low revenue growth compared to the industry average suggests a potential challenge in increasing sales volume, which could be a concern for long-term growth.